Latest News

Quanta in the News.

26 October 2015.  Seroba’s investee company, Quanta Fluid Solutions, has this week announced it has successfully treated the first patients with its portable, cartridge-based haemodialysis system.  The company has also featured on the BBC News in the UK. The treatments were part of a pilot study designed to demonstrate safety, performance and usability of SC+ in a clinical...


Quanta Receives £1.85 Million i4i Award.

Seroba investee company, Quanta Fluid Solutions, Receives £1.85 Million i4i Award to Develop an Advanced Haemodialysis System for Nocturnal Use.

Alcester, Warwickshire, UK, 18 August 2015: Seroba investee company, Quanta Fluid Solutions Ltd (“Quanta” or the “Company”), a pioneering developer of...


Heart Metabolics and FDA Reach Agreement on Special Protocol Assessment.

Dublin – April 15, 2015 – Seroba's investee company, Heart Metabolics Limited, a biotechnology company focused on the development of drugs for orphan diseases including hypertrophic cardiomyopathy (HCM), today announced that it has received an agreement letter from the U.S. Food and Drug Administration (FDA) related to the company’s proposed Phase 3 trial Special Protocol...


< back to home page